HER-2/neu peptide vaccine
MC1136
Phase 1 mab completed
Quick answer
HER-2/neu peptide vaccine for HER2-positive Breast Cancer is a Phase 1 program (mab) at Marker Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Marker Therapeutics
- Indication
- HER2-positive Breast Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- completed